Huadong Medicine Co. Investor Relations Material
Latest events
Q1 2025
25 Apr, 2025
Q4 2024
17 Apr, 2025
Access the full event backlog
Slides, Transcripts, and Reports from 13,000 public companies
Latest reports from Huadong Medicine Co. Ltd
Access all reports
Huadong Medicine Co., Ltd. is engaged in the research, development, manufacturing, and distribution of pharmaceutical products. The company’s offerings include a wide range of prescription drugs, over-the-counter medications, and healthcare products used in fields such as oncology, nephrology, endocrinology, and immunology. In addition to pharmaceuticals, Huadong Medicine operates in the medical aesthetics and biotechnology sectors. The company is headquartered in Hangzhou, China, and its shares are listed on the SZSE.
Latest articles
)
Pershing Square Capital Management: Conviction, Reinvention, and Contrarian Investing
Pershing Square Capital Management has grown into a top-tier hedge fund through reinvention, conviction, and focus on long-term value creation.
2 Jul 2025
)
Eli Lilly: The Pharma Giant Behind Mounjaro and Zepbound
Eli Lilly's journey from insulin pioneer to global pharma giant, leading innovation in diabetes, obesity, and the future of metabolic health.
30 Jun 2025
)
500 Years of Craft, One Family Legacy: Beretta Holding's Global Expansion
How Beretta Holding managed to transform from a 16th-century gun barrel producer into a global industrial group while preserving 500 years of legacy.
27 Jun 2025
Ticker symbol
963
Country
🇨🇳 China